SG Americas Securities
FBIO icon

SG Americas Securities’s Fortress Biotech FBIO Stock Holding History

SG Americas Securities’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,641
Closed -$79K – 3521
2021
Q3 		$79K Buy
+1,641
New +$80.1K ﹤0.01% 3697
2020
Q3 		– Sell
-2,108
Closed -$85K – 2924
2020
Q2 		$85K Buy
+2,108
New +$78.3K ﹤0.01% 3431
2019
Q1 		– Sell
-2,967
Closed -$38K – 3419
2018
Q4 		$38K Buy
+2,967
New +$49.5K ﹤0.01% 2856
2016
Q2 		– Sell
-933
Closed -$43K – 2720
2016
Q1 		$43K Buy
+933
New +$39.4K ﹤0.01% 2778
2013
Q4 		– Sell
-1,712
Closed -$180K – 2744
2013
Q3 		$180K Buy
+1,712
New +$210K ﹤0.01% 2255

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

SG Americas Securities's FBIO Position: Q4 2021 in Review

SG Americas Securities sold out of Fortress Biotech (FBIO) in Q4 2021, closing a stake of 1,641 shares — an estimated $79K sold.

SG Americas Securities first reported a position in FBIO in Q3 2013 and held it in 5 quarters. The position peaked at $180K in Q3 2013. 82 funds tracked by Wall St. Rank hold FBIO as of Q4 2021.

  • SG Americas Securities reported no remaining Fortress Biotech position as of Q4 2021 after selling out during the quarter.
  • SG Americas Securities sold 1,641 Fortress Biotech shares in Q4 2021, an estimated $79K.
  • SG Americas Securities first reported a position in Fortress Biotech in Q3 2013 and held it in 5 quarters.
  • SG Americas Securities's Fortress Biotech position peaked at $180K in Q3 2013.
  • 82 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2021.

Based on SG Americas Securities's 13F filing for Q4 2021, filed 7 Feb 2022.